Compare Indonesia Energy Corporation Limited (INDO) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesia Energy Corporation Limited vs Medpace Holdings Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.77 (market cap $43.24M), while Medpace Holdings Inc trades at $611.57 (market cap $16.82B). The key difference: Medpace Holdings Inc is far larger — about 389× Indonesia Energy Corporation Limited's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indonesia Energy Corporation Limited for 24 Days and Medpace Holdings Inc for 14 Days on average.
| INDO | MEDP | |
|---|---|---|
Market Cap | $43.24M | $16.82B |
Volume | 116,953 | 223,093 |
Sector | Energy | Health |
52-Week High | $6.74 | $630.19 |
52-Week Low | $2.49 | $393.42 |
Typical Hold Time | 24 Days | 14 Days |
Enterprise Value | $38.18M | $16.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Indonesia Energy Corporation (INDO) trades at $2.79, up 0.72% with bearish technical signals despite 100% analyst buy ratings. The oil and gas explorer shows severe financial distress with negative margins (-152.72% net income) and cash burn, though recent K-29 well discoveries offer operational catalysts. Revenue remains minimal at $2.01M while losses persist, creating high-risk speculation around drilling success.
Outlook hinges on production scaling from new wells, but current fundamentals don't support valuation. High execution risk and cash flow concerns warrant caution despite optimistic analyst coverage. The stock represents a binary bet on operational turnaround versus ongoing financial deterioration.
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
